The objective of the Administrative Core is to allow the principal investigators to focus their energies on the scientific aspects of the study plan. Recognizing that the PI is ultimately responsible for all aspects of the award, it is the aim of the administrative core to handle all non-scientific tasks that pertain to the conduct of this research. To facilitate communication, coordination and planning among the projects and the PI, Dr. Clapham will be assisted by a Laboratory/scientific-program Administrator. The PI and the Administrator will meet weekly to ensure that the PI is fully informed and an active participant in the process of Administration. The Administrative Core has three specific aims:
Aim 1 is to assist the PI and his colleagues with fiscal management ofthe award. This includes processing award notices from the NIH, managing project budgets, and assisting in the preparation of annual progress reports to the NIH. The Children's Hospital Office of Sponsored Programs (OSP) is staffed with grants management specialists who concentrate on pre-award aspects of research awards. Post-award oversight is the joint responsibility ofthe OSP and the Office of Research Finance (RFO). The Laboratory/scientific- program Administrator is responsible for daily pre- and post-award activities.
Aim 2 is to provide clerical support to the PI and his colleagues for tracking annual renewals of animal and human protocols, manuscript preparation, traveling and scheduling as it pertains to the program.
Aim 3 is to assist the PI and his colleagues in ensuring effective communication, coordination and planning for the program. The laboratory/scientific-program Administrator will schedule and facilitate monthly research update and planning meetings to be attended by each project/core leader and the PI. The internal advisory board (Corey, Yellen, Ji) will be invited on a quarterly basis to attend the research update meeting, and external advisors (Julius, Caterina, Basbaum) will be invited to attend yearly, to provide their fresh perspectives and guidance.

National Institute of Health (NIH)
Research Program Projects (P01)
Project #
Application #
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Children's Hospital Boston
United States
Zip Code
Ellis, Samantha; Kalinowski, Danuta S; Leotta, Lisa et al. (2014) Potent antimycobacterial activity of the pyridoxal isonicotinoyl hydrazone analog 2-pyridylcarboxaldehyde isonicotinoyl hydrazone: a lipophilic transport vehicle for isonicotinic acid hydrazide. Mol Pharmacol 85:269-78
Kahle, Kristopher T; Khanna, Arjun; Clapham, David E et al. (2014) Therapeutic restoration of spinal inhibition via druggable enhancement of potassium-chloride cotransporter KCC2-mediated chloride extrusion in peripheral neuropathic pain. JAMA Neurol 71:640-5
Jo, Sooyeon; Bean, Bruce P (2014) Sidedness of carbamazepine accessibility to voltage-gated sodium channels. Mol Pharmacol 85:381-7
Brenneis, C; Kistner, K; Puopolo, M et al. (2014) Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block. Br J Pharmacol 171:438-51
Ma, Qiufu (2014) Merkel cells are a touchy subject. Cell 157:531-3
Py, Bénédicte F; Jin, Mingzhi; Desai, Bimal N et al. (2014) Caspase-11 controls interleukin-1? release through degradation of TRPC1. Cell Rep 6:1122-8
Duan, Bo; Cheng, Longzhen; Bourane, Steeve et al. (2014) Identification of spinal circuits transmitting and gating mechanical pain. Cell 159:1417-32
Prescott, Steven A; Ma, Qiufu; De Koninck, Yves (2014) Normal and abnormal coding of somatosensory stimuli causing pain. Nat Neurosci 17:183-91
Chiu, Isaac M; Heesters, Balthasar A; Ghasemlou, Nader et al. (2013) Bacteria activate sensory neurons that modulate pain and inflammation. Nature 501:52-7
Puopolo, Michelino; Binshtok, Alexander M; Yao, Gui-Lan et al. (2013) Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314. J Neurophysiol 109:1704-12

Showing the most recent 10 out of 15 publications